German Airlines Stock News

thyssenkrupp nucera KGaA (XTRA:NCH2) just landed a high double digit million euro contract to supply electrolysers for a new large scale Chlor Alkali plant in the Middle East, sharpening attention on its stock. See our latest analysis for thyssenkrupp nucera KGaA. The latest contract win comes after a choppy spell for the stock, with a 90 day share price return of minus 19.54 percent and a 1 year total shareholder return of minus 23.44 percent. This suggests sentiment may be stabilising...

Earlier this month, Kepler Cheuvreux upgraded Deutsche Lufthansa’s rating from Hold to Buy, highlighting progress in its turnaround program and potential benefits from sector-wide factors like capacity constraints and lower fuel costs. The broker also pointed to Lufthansa’s growing focus on premium long-haul travel and its Eurowings expansion as areas where shifting global demand patterns could enhance the group’s competitive position. Next, we’ll examine how this upgrade and confidence in...

Earlier this month, Fresenius SE & Co. KGaA held its Analyst/Investor Day, outlining a plan to double its biopharma revenue and portfolio by 2030 while targeting a 20% EBIT margin through innovation, cost leadership, and global commercial expansion. Management emphasized that a robust biopharma pipeline, strong underlying financial performance, and significant R&D and manufacturing investments are intended to support this long-term value creation roadmap. We’ll now explore how Fresenius’s...

Stabilus SE's ( ETR:STM ) earnings announcement last week didn't impress shareholders. Despite the soft profit numbers...

Key Insights Using the Dividend Discount Model, E.ON fair value estimate is €18.01 E.ON's €15.36 share price indicates...

We feel now is a pretty good time to analyse SBF AG's ( FRA:CY1K ) business as it appears the company may be on the...

Unless you borrow money to invest, the potential losses are limited. But when you pick a company that is really...

Let's talk about the popular Heidelberg Materials AG ( ETR:HEI ). The company's shares saw a decent share price growth...

In recent days, Lemongrass and RESAAS each announced new partnerships with SAP under the PartnerEdge program, aiming to embed their AI and real-time data solutions more tightly into SAP’s Business Technology Platform and enterprise analytics stack. These collaborations, together with SAP’s emphasis on an application–data–AI flywheel and employee-led innovation, underline how the company is working to keep its software central to mission-critical workflows as customers modernize in an AI...

In December 2025, AlzChem Group AG approved a roughly €120 million investment program to build a more automated creatine production plant and related infrastructure, with phased commissioning scheduled from the second half of 2027 to capture additional demand in sports, food, and health. The company links this capacity expansion to early triple-digit million euro annual sales potential from its Creapure® and Creavitalis® lines, underscoring how nutrition and wellness trends are reshaping its...

Key Insights MBB's estimated fair value is €353 based on 2 Stage Free Cash Flow to Equity MBB is estimated to be 42...

Earlier this month, Kraken and Deutsche Börse Group announced a partnership to connect traditional financial markets with digital assets across trading, custody, settlement, collateral management, and tokenized products, initially via a direct integration between Kraken and FX venue 360T. The collaboration could position Deutsche Börse as a core infrastructure provider for institutional crypto and tokenized asset access in Europe and the U.S., reinforcing its role in the development of...

Siemens Healthineers AG previously announced an annual dividend of €1.00 per share, payable on February 10, 2026, with an ex-dividend date of February 6, 2026 and a record date of February 9, 2026. ALZpath, Inc. has licensed its proprietary pTau217 antibody to Siemens Healthineers, enabling development of an Alzheimer's diagnostic assay for Atellica systems that could expand the company’s higher-value in vitro testing portfolio. We’ll now examine how adding an ALZpath-powered Alzheimer’s...

Stock pickers are generally looking for stocks that will outperform the broader market. And in our experience, buying...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

CompuGroup Medical SE & Co. KGaA's ( HMSE:COP ) price-to-earnings (or "P/E") ratio of 72.1x might make it look like a...

TUI (XTRA:TUI1) just wrapped up its fiscal year with higher sales and net income than last year, and paired those results with a fresh annual dividend announcement that underlines management’s confidence. See our latest analysis for TUI. The upbeat full year numbers and fresh dividend seem to have lit a fire under sentiment, with a 30 day share price return of 14.61 percent helping push the stock to 8.878 dollars, even though the five year total shareholder return remains negative. This...

TeamViewer recently appointed Finn Faldi as Executive Vice President Global Inside Sales, adding him to the Senior Leadership Team to unify inside sales across the Americas, EMEA and APAC, while President TeamViewer Americas Georg Beyschlag is set to depart after more than seven years in leadership roles. Faldi’s return, following his prior tenure scaling TeamViewer’s Americas operations and later advising the company, underscores management’s focus on sharpening its commercial engine to...

All for One Group (XTRA:A1OS) has just posted its FY 2025 Q3 numbers, with revenue at €122.8 million and EPS of €0.14, marking another quarter of modest profitability following last year’s improvement in earnings. The company has seen revenue hover around the €122 million to €134 million range over recent quarters, while EPS has swung from €0.11 in FY 2024 Q3 to €1.33 in FY 2025 Q1 and now €0.14 in Q3. This pattern places greater emphasis on how consistently those profits can translate into...

Deutsche Lufthansa (XTRA:LHA) jumped after Kepler Cheuvreux raised its rating to Buy, highlighting a turnaround plan that is mostly scheduled for execution next year along with improving conditions in long-haul travel. See our latest analysis for Deutsche Lufthansa. The rating upgrade lands on top of already strong momentum, with a 37.48% year to date share price return and a 33.38% one year total shareholder return suggesting confidence in Lufthansa’s multi year recovery story. If this...

MVV Energie (XTRA:MVV1) just reported a 15% drop in annual profit as past windfall gains faded, yet it chose to lift its dividend and step up spending on renewables and green heat. See our latest analysis for MVV Energie. Despite the softer earnings, the share price has been steady, with the latest close at €31.60 and a 3 month share price return of 3.61 percent. A 5 year total shareholder return of 48.88 percent suggests patient investors have still been rewarded as the market gradually...

SCHOTT Pharma AG & Co. KGaA ( ETR:1SXP ) has announced that it will be increasing its periodic dividend on the 6th of...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

As the European markets navigate mixed performances, with notable fluctuations in major indices like Germany’s DAX and France’s CAC 40, investors continue to assess opportunities amidst economic uncertainties. Penny stocks, though a term from past market eras, still hold potential for those seeking value in smaller or newer companies. These stocks can offer affordability and growth potential when supported by strong financials, making them intriguing options for investors looking beyond...